{
  "company": {
    "name": "Entrada Therapeutics",
    "website": "https://entradatx.com/",
    "record": "https://startuphistory.org/c/entradatx.com"
  },
  "status": null,
  "history_since": "2018-10-29T20:13:26.000Z",
  "baseline": {
    "snapshot_id": "482c4d712321539e35da2ef979b9cdb9cf85a1af9b0ea3ce910cfc7d34c8a7f2",
    "observed_at": "2018-10-29T20:13:26.000Z",
    "headline": "Entrada Therapeutics is building the leading intracellular biologics company to transform the treatment of devastating diseases",
    "description": null,
    "evidence": "https://web.archive.org/web/20181029201326/https://www.entradatx.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-06T16:53:53.439Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2025-07-18T22:30:04.000Z",
      "variants": [
        {
          "headline": "Entrada Therapeutics is building the leading intracellular biologics company to transform the treatment of devastating diseases",
          "subhead": null,
          "observed_at": "2018-10-29T20:13:26.000Z",
          "evidence": "https://web.archive.org/web/20181029201326/https://www.entradatx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Making Intracellular Biologics a Reality",
          "subhead": "Entradatx",
          "observed_at": "2019-07-20T11:21:38.000Z",
          "evidence": "https://web.archive.org/web/20190720112138/https://www.entradatx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Making Intracellular Therapeutics A Reality",
          "subhead": "Overcoming the challenge of intracellular target access to transform the treatment of devastating diseases",
          "observed_at": "2022-01-27T16:54:43.000Z",
          "evidence": "https://web.archive.org/web/20220127165443/https://www.entradatx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Making Intracellular Therapeutics A Reality",
          "subhead": "Overcoming the challenge of intracellular target access to transform the treatment of devastating diseases",
          "observed_at": "2023-01-12T23:31:53.000Z",
          "evidence": "https://web.archive.org/web/20230112233153/https://www.entradatx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Making Intracellular Therapeutics A Reality",
          "subhead": "Overcoming the challenge of intracellular target access to transform the treatment of devastating diseases",
          "observed_at": "2024-01-05T17:09:44.000Z",
          "evidence": "https://web.archive.org/web/20240105170944/https://www.entradatx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Making Intracellular Therapeutics A Reality",
          "subhead": "Overcoming the challenge of intracellular target access to transform the treatment of devastating diseases.",
          "observed_at": "2024-07-09T12:20:25.000Z",
          "evidence": "https://web.archive.org/web/20240709122025/https://www.entradatx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Making Intracellular Therapeutics A Reality",
          "subhead": "Overcoming the challenge of intracellular target access to transform the treatment of devastating diseases.",
          "observed_at": "2025-07-18T22:30:04.000Z",
          "evidence": "https://web.archive.org/web/20250718223004/https://www.entradatx.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Making Intracellular Therapeutics A Reality",
      "subhead": "Overcoming the challenge of intracellular target access to transform the treatment of devastating diseases.",
      "from": "2018-10-29T20:13:26.000Z",
      "to": "2025-07-18T22:30:04.000Z",
      "captures": 7,
      "evidence": "https://web.archive.org/web/20250718223004/https://www.entradatx.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2018-10-29T20:13:26.000Z",
          "to": "2025-07-18T22:30:04.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-06T16:53:53.439Z",
      "variants": [
        {
          "headline": "Meet Max, living with Duchenne Muscular Dystrophy",
          "subhead": "Overcoming the challenge of intracellular target access to transform the treatment of devastating diseases.",
          "observed_at": "2026-07-15T06:52:48.000Z",
          "evidence": "https://web.archive.org/web/20260715065248/https://www.entradatx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Meet Max, living with Duchenne Muscular Dystrophy",
          "subhead": "Overcoming the challenge of intracellular target access to transform the treatment of devastating diseases.",
          "observed_at": "2026-11-06T16:53:53.439Z",
          "evidence": "https://www.entradatx.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "Meet Max, living with Duchenne Muscular Dystrophy",
      "subhead": "Overcoming the challenge of intracellular target access to transform the treatment of devastating diseases.",
      "from": "2026-07-15T06:52:48.000Z",
      "to": "2026-11-06T16:53:53.439Z",
      "captures": 2,
      "evidence": "https://www.entradatx.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2026-07-15T06:52:48.000Z",
          "to": "2026-11-06T16:53:53.439Z"
        }
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-482c4d712321539e35da2ef979b9cdb9cf85a1af9b0ea3ce910cfc7d34c8a7f2:d7787e8d8e405f430d8d7fe57c2033db3dda151e416cf9a1f917a4f5670292c9:funding:6387fabd418a4278",
      "before_evidence": "https://web.archive.org/web/20181029201326/https://www.entradatx.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "funding",
      "label": "Funding",
      "summary": "Announced on its homepage: “Read more March 19, 2019 Entrada Therapeutics Raises $59 Million Series A to Advance Intracellular Biologics Platform December 18, 2018 B…”.",
      "between": {
        "from": "2018-10-29T20:13:26.000Z",
        "to": "2019-07-20T11:21:38.000Z"
      },
      "evidence": "https://web.archive.org/web/20190720112138/https://www.entradatx.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/announced-funding"
    },
    {
      "n": 2,
      "id": "page-482c4d712321539e35da2ef979b9cdb9cf85a1af9b0ea3ce910cfc7d34c8a7f2:d7787e8d8e405f430d8d7fe57c2033db3dda151e416cf9a1f917a4f5670292c9:headline:64f0df5376fad9c1",
      "before_evidence": "https://web.archive.org/web/20181029201326/https://www.entradatx.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “Entrada Therapeutics is building the leading intracellular biologics company to transform the treatment of devastating diseases” to “Making Intracellular Biologics a Reality”.",
      "between": {
        "from": "2018-10-29T20:13:26.000Z",
        "to": "2019-07-20T11:21:38.000Z"
      },
      "evidence": "https://web.archive.org/web/20190720112138/https://www.entradatx.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    },
    {
      "n": 3,
      "id": "page-482c4d712321539e35da2ef979b9cdb9cf85a1af9b0ea3ce910cfc7d34c8a7f2:d7787e8d8e405f430d8d7fe57c2033db3dda151e416cf9a1f917a4f5670292c9:hiring:20dd4c09cc4ab0aa",
      "before_evidence": "https://web.archive.org/web/20181029201326/https://www.entradatx.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "hiring",
      "label": "Hiring",
      "summary": "Added a careers page.",
      "between": {
        "from": "2018-10-29T20:13:26.000Z",
        "to": "2019-07-20T11:21:38.000Z"
      },
      "evidence": "https://web.archive.org/web/20190720112138/https://www.entradatx.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/added-careers-page"
    },
    {
      "n": 4,
      "id": "page-bf1b75aab348840847eb278f105eab83248d1f06c37772c55d9b3d739c7dddcc:8d20b0a35d181554e1a285911b18b456e6ad4d22edb4802518ef9ce10ffb1862:headline:054eafef0901b0e5",
      "before_evidence": "https://web.archive.org/web/20250718223004/https://www.entradatx.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “Making Intracellular Therapeutics A Reality” to “Meet Max, living with Duchenne Muscular Dystrophy”.",
      "between": {
        "from": "2025-07-18T22:30:04.000Z",
        "to": "2026-07-15T06:52:48.000Z"
      },
      "evidence": "https://web.archive.org/web/20260715065248/https://www.entradatx.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    }
  ],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Entrada Therapeutics” company record, https://startuphistory.org/c/entradatx.com"
}